Researcher
Chris Verhofstede
- Keywords:HIV
- Disciplines:Infectious diseases, Clinical microbiology, Virology
Affiliations
- Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → Today - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Jan 1993 → 30 Sep 2018
Projects
1 - 7 of 7
- Aids Reference Laboratory - werkingsjaar 2023From1 Jan 2023 → 31 Dec 2023Funding: Ministery of Social Affairs, Public Health and Environment
- Aids Reference Lab - werkingsjaar 2022From1 Jan 2022 → 31 Dec 2022Funding: Ministery of Social Affairs, Public Health and Environment
- AIDS Reference Lab 2019 (2nd semester) - 2020 and 2021From1 Jan 2021 → 31 Dec 2021Funding: Ministery of Social Affairs, Public Health and Environment
- AIDS Reference Lab 2019 (2nd semester) - 2020 and 2021From1 Jan 2020 → 31 Dec 2020Funding: Ministery of Social Affairs, Public Health and Environment
- AIDS Reference Lab 2019From1 Jan 2019 → 31 Dec 2019Funding: Ministery of Social Affairs, Public Health and Environment
- AIDS Reference LabFrom1 Jan 2017 → 31 Dec 2017Funding: Ministery of Social Affairs, Public Health and Environment
- Aids Reference Lab 2017-2018From1 Jan 2017 → 31 Dec 2018
Publications
1 - 10 of 61
- Towards novel HIV-1 serodiagnostic tests without vaccine-induced seroreactivity(2023)
Authors: Ole Lagatie, Dax Lauwers, Harvinder Singh, Fien Vanroye, Daniel J. Stieh, Johan Vingerhoets, Ludo Lavreys, Valérie Oriol-Mathieu, Will Colón, Chris Verhofstede, et al.
- Prevalence and evolution of transmitted human immunodeficiency virus drug resistance in Belgium between 2013 and 2019(2022)
Authors: Laurent Debaisieux, Geraldine Dessilly, Karolien Stoffels, Dolores Vaira, Ellen Vancutsem, Kristel Van Laethem, Fien Vanroye, Chris Verhofstede
- Screening algorithms for HBV, HCV, HIV and syphilis in an anatomical donation program(2022)
Authors: Koen Vercauteren, Elizaveta Padalko, Chris Verhofstede
- Impact of COVID-19 on the Belgian HIV epidemic : slowdown of HIV transmission and testing and adaptation of care(2022)
Authors: D Van Beckhoven, B Serrien, M Montourcy, Chris Verhofstede, D Van den Bossche, A Libois, D De Geyter, T Martin, S Van den Eynde, B Vuylsteke, et al.
- Benefits of antiretroviral therapy initiation during acute HIV infection(2022)
Authors: Jozefien De Clercq, Marie-Angélique De Scheerder, Chris Verhofstede
Pages: 168 - 176 - High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing(2020)
Authors: Laura Hebberecht, Kenny Dauwe, Karolien Stoffels, Fien Vanroye, Marie-Luce Delforge, Ellen Vancutsem, Géraldine Dessilly, Dolorès Vaira, Kristel Van Laethem, Chris Verhofstede
- Chronic and early antiretroviral therapy impact Human Immunodeficiency Virus (HIV) serological assay sensitivity, leading to more false-negative test results in HIV diagnosis(2020)
Authors: Karolien Stoffels, Fien Vanroye, Laurent Debaisieux, Marie-Luce Delforge, Melissa Depypere, Géraldine Dessilly, Dolores Vaira, Ellen Vancutsem, Sigi Van den Wijngaert, Kristel Van Laethem, et al.
Pages: 1660 - 1669 - Earlier initiation of antiretroviral treatment coincides with an initial control of the HIV-1 sub-subtype F1 outbreak among men-having-sex-with-men in Flanders, Belgium(2019)
Authors: Lore Vinken, Katrien Fransen, Lize Cuypers, Ivailo Alexiev, Claudia Balotta, Laurent Debaisieux, Carole Seguin-Devaux, Sergio García Ribas, Perpétua Gomes, Francesca Incardona, et al.
- Single genome sequencing of near full-length HIV-1 RNA using a limiting dilution approach(2019)
Authors: Laura Hebberecht, Leen Vancoillie, Marlies Schauvliege, Delfien Staelens, Els Demecheleer, Jarryt Hardy, Virginie Mortier, Chris Verhofstede
- HIV rebound is predominantly fueled by genetically identical viral expansions from diverse reservoirs(2019)
Authors: Marie-Angélique De Scheerder, Bram Vrancken, Simon Dellicour, Timothy Schlub, Eunok Lee, Wei Shao, Sofie Rutsaert, Chris Verhofstede, Tessa Kerre, Thomas Malfait, et al.
Pages: 347 - 358